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A New MHC Locus That Influences
Class I Peptide Presentation
MHC-encoded heavy chain, b2-microglobulin, and pep-
tide (reviewed in Townsend and Bodmer, 1989; Ram-
mensee et al., 1993). The biosynthesis of this trimolecu-
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lar complex within the endoplasmic reticulum (ER)Shanna D. Maika,2 Ming Zhou,1 Simon J. Gaskell,5
requires the participation of several other molecules thatRobert S. Bordoli,7 Hidde L. Ploegh,6,10
are not part of the final complex (reviewed in HeemelsClive A. Slaughter,2 Kirsten Fischer Lindahl,2,3
and Ploegh, 1995; Lehner and Cresswell, 1996; York andRobert E. Hammer,2 and Joel D. Taurog1,8
Rock, 1996; Koopmann et al., 1997). Among these are1 Harold C. Simmons Arthritis Research
the multisubunit, multicatalytic proteasome complexCenter
that generates peptides through degradation of cyto-Department of Internal Medicine
solic and nuclear proteins, two subunits of which, LMP22 Howard Hughes Medical Institute
and LMP7, are encoded within the MHC (Fehling et al.,Department of Biochemistry
1994; Van Kaer et al., 1994; Groettrup et al., 1996); the3 Department of Microbiology
heterodimeric transporter associated with antigen pro-University of Texas Southwestern Medical
cessing (TAP) that transports peptides from the cytosolCenter
into the ER (Van Kaer et al., 1992; van Endert et al.,Dallas, Texas 75235
1994), the genes for which are tightly linked to those for4 The Jackson Laboratory
LMP2 and LMP7 within the MHC; calnexin, a 64.5 kDaBar Harbor, Maine 04609
phosphorylated transmembrane protein that binds tran-5 Department of Chemistry
siently to a variety of proteins, including newly synthe-UMIST
sized class I heavy chain, during their folding and/orManchester M60 1QD
oligomeric assembly in the ER (reviewed in HammondUnited Kingdom
and Helenius, 1995); calreticulin, a 60 kDa soluble homo-6 Center for Cancer Research
log of calnexin, which binds the complex of heavy chainMassachusetts Institute of Technology
and b2m (Sadasivan et al., 1996); and a recently de-Cambridge, Massachusetts 02139
scribed 48 kDa molecule, tapasin, which is thought to7 Micromass UK Ltd.
form a bridge between the MHC heavy chain and theWythenshaw Manchester M23 9LE
TAP transporter (Sadasivan et al., 1996; Ortmann et al.,United Kingdom
1997).
Within a species, allelic variation of the MHC class ISummary
heavy chain loci gives rise to extensive polymorphism in
surface-expressed MHC±peptide complexes. However,We have investigated the HLA-B27-restricted CTL re-
allelic variation in any of the other loci that participatesponse to HY minor histocompatibility antigens in
in the generation of MHC-bound peptides can also po-rats and mice transgenic for HLA-B27 and human
tentially influence the antigenic array of surface-dis-b2-microglobulin. A polymorphism was found at a lo-
played MHC±peptide complexes. In the case of the Tap2cus within the H2 complex, producing two distinct but
gene encoded within the class II region of the MHC, theoverlapping sets of B27-presented HY peptides. The
rat has two allelic forms that show distinctly differentlocus, named Cim2, mapped between the K and Pb
specificities of peptide transport and that can resultloci, and its product is therefore distinct from TAP,
in the loading and surface display of differing sets ofLMP, and tapasin. Identical findings in rats and mice,
peptides when paired with the class I heavy chain alleleincluding identical HY peptide sequences and the fail-
RT1.Aa (Powis et al., 1992, 1996). The Tap2 locus wasure of a rat Tap2A transgene to alter CTL recognition,
originally discovered in rats at this functional level, assuggest that a homologous locus with similar poly-
a consequence of allelic differences in the allorec-morphism exists in the rat. Cim2, or a closely linked
ognition of MHC class I RT1.Aa molecules (Livingstonelocus, was found to exert a broad effect on peptide
et al., 1989). Two alleles were described at a locus, cimloading of both HLA-B27and mouse class I alleles. The
(class I modifier), which mapped to the MHC class IIdata thus establish a strong, previously unrecognized
region and influenced the intracellular maturation andMHC-encoded influence on the class I antigen pathway.
cell-surface expression of RT1.Aa molecules (Living-
stone et al., 1991; Powis et al., 1991a). It was demon-Introduction
strated by transfection studies that the main features of
the cim phenomenon result from polymorphism of theMHC class I molecules expressed on cell surfaces pres-
heterodimeric peptide transporter, TAP2 (Deverson etent peptide antigen to CD81 T cells as a complex of
al., 1990; Powis et al., 1992). No functional polymor-
phism has been found for TAP in either mice or humans
8 To whom correspondence should be addressed (e-mail: taurog@ (Schumacher et al., 1994; Obst et al., 1995), nor for any
utsw.swmed.edu).
of the other molecules known to participate in the as-9 Present Address: SmithKlineBeecham, Welwyn, Hertfordshire AL6
sembly of the peptide/MHC class I complex. Here, we9AR, United Kingdom.
present evidence for a functionally novel locus in both10 Present Address: Department of Pathology, Harvard Medical
School, Boston, Massachusetts 02115. mice and rats, the product of which participates in the
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class I antigen processing pathway. This locus maps
within the mouse H2 complex between K and Pb, and
it is thus distinct from the loci known to affect class I
assembly, including Tap1 and Tap2.
Results
Lymphoblast Targets from B27 Transgenic Mice
Show H2-Linked Differences in Susceptibility
to Lysis by B27-Restricted Anti-HY CTL
We previously reported that the B27-restricted HY anti-
gen is identical in rats bearing RT1l or RT1a (both cima)
and in mice bearing H2b or H2s, as recognized by CTL
raised in rats bearing RT1l (Simmons et al., 1993, 1997),
whereas quantitatively less of this antigen is expressed
on rat targets bearing RT1c (cimb) (Simmons et al., 1996).
Although we attributed the difference in HY presentation
between cima and cimb rats to the alleles of the rat
Tap2 locus (Simmons et al., 1996), these results were
somewhat puzzling, because the results in mice were
similar to those in cima rats, yet the peptide specificity
of mouse TAP much more closely resembles rat TAP2B
(cimb) than TAP2A (cima) (Momburg et al., 1994; Neefjes
Figure 1. Similar Dimorphic Expression of the B27-Presented HYet al., 1995). We therefore sought MHC-linked variation
Antigen on Rat and Mouse ConA Lymphoblastsin B27-presented HY in mice.
Polyclonal B27-restricted, anti-HY CTL were generated in 21-4L ratsWhen ConA lymphoblasts from several inbred mouse
(LEW, RT1l, cima), as described in Experimental Procedures andstrains, onto which the 56-3 B27/hb2m transgene locus previously (Simmons et al., 1993, 1996, 1997). In subsequent figures,
had been backcrossed, were tested as targets for lysis these CTL effectors are referred to as rat Cim2a CTL. The B27/hb2m
by the B27-restricted anti-HY CTL raised in RT1l rats, transgene locus of the 56-3 mouse line (originally B6 3 SJL hybrid
two patterns were seen that were very similar to the background, Taurog et al., 1990), was backcrossed >10 generations
to the B6, BALB/c, SJL, C3H, and MRL inbred mouse strains topatterns distinguishing cima and cimb rat targets (Figure
produce congenic lines. The BALB.B.56-3 line was produced by1). The C57BL/6 (B6), SJL, and BALB.B targets were
backcrossing twice from the BALB/c.56-3 line. The B27/hb2mlysed at the high levels comparable to those of cima rat
transgene locus of the 33-3 rat line (originally F344, Hammer et al.,
targets, whereas the BALB/c, C3H, and MRL transgenic 1990) was backcrossed >8 generations to the inbred DA and PVG
targets were lysed at significantly lower levels, compara- rat strains. ConA blast targets from the indicated mice and rats were
ble to those of cimb rat targets. tested for lysis by the B27-restricted anti-HY CTL. Targets from each
congenic line were tested in at least three separate experiments (2The finding that targets from BALB.B.56-3 mice, but
for BALB.B.56-3), all with identical results.not BALB/c.56-3 mice, were lysed at levels as high as
the other transgenic H2b targets, indicated that the effect
H2k haplotype, but possesses H2-Ks as a result of ais linked to the H2 complex, and also therefore trans-
recombination event z50±75 kb centromeric to Pb. Theacting with respect to the B27 transgene. Moreover,
telomeric boundary of this locus is delimited by thethe high lysis pattern of targets from (BALB/c.56-3 3
haplotype of the congenic B10.CAS4(9887) strain, whichBALB.B)F1 mice (Table 1) suggested that the high lysis
bears alleles of the H2b haplotype throughout the Pb-allele is dominant. All three of these characteristics are
Ma-Lmp-Tap regions but carries H2-Kc4 from the Musshared by the cim locus of the rat (Livingstone et al.,
musculus castaneus haplotype cas4 as a result of a1989). However, given the documentedabsence of func-
recombination event at the centromeric end of Pb (T.tional polymorphism in mouse TAP (Schumacher et al.,
Isobe and T. Shirioshi, personal communication; K. F. L.,1994; Obst et al., 1995), further geneticmapping seemed
unpublished data). The locus was thus mapped withincalled for.
the z50±75 kb region between the B10.CAS4(9887) and
A.TL recombination sites, centromeric to Pb and telo-
The H2-Linked Locus Affecting CTL Lysis Maps meric to K. The results from the crosses with the
between K and Pb, Centromeric to the B10.MBR and B10.CAS3(R0) strains are also consistent
Tap±Lmp Complex with a map positioncentromeric to Ma and Lmp, respec-
To genetically map the allelic effect on B27-restricted, tively.
HY-specific lysis, a series of F1 crosses were made The locus was thus formally separated from the Lmp±
between C3H.56-3 or BALB/c.56-3 mice, which carry Tap complex, which lies telomeric to Ma, and from the
the low lysis recessive H2-linkedallele, and mice bearing locus encoding the recently described tapasin protein
native or recombinant H2 haplotypes. The results, (Sadasivan et al., 1996; Ortmann et al., 1997), which is
shown in Table 1, mapped the effect to the K side (cen- linked to H2 but has now been mapped centromeric to
tromeric) of the Tap/Lmp region. The centromeric H2-K (K. F. L., unpublished data). The new locus was
boundary is delimited by the haplotype of the congenic provisionally named Cim2 (MHC class I modifier-2) be-
cause of its functional similarity to cim (Livingstone etA.TL strain, which bears predominantly alleles of the
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Table 1. The Cim2 Locus Maps between K and Pb in the Mouse H2 Complex
Male Targets H2 Haplotype K Pb Ma Lmp/Tap E D % Lysis (E:T 5 100:1)
Cim2a Haplotypes
F1: C3H.56-3 3
B10.A(5R) i5 b b b b b/k d 96, 94
A.SW s s s s s s s 88, 93, 90
A.BY b b b b b b b 81, 91, 84
A.TH t2 s s s s s | d 92, 97, 81
B10.MBR bq1 b b ← k k k | q 90, 86, 84, 86
F1: BALB/c.56-3 3
BALB.B b b b b b b b 83, 88, 84
Cim2b Haplotypes
F1: C3H.56-3 3
B10.A(2R) h2 k k k k k | b 46, 49
B10.A(4R) h4 k k k k k/b b 48, 54
B10.D2/o d d d d d d d 51, 48
B10.A a k k k k k | d 50, 55
A/J a k k k k k | d 60, 55
A.CA f f f f f f f 44, 49, 42
B10.AKM m k k k k k | q 45, 48 46, 49
A.TL t1 s → k k k k | d 43, 52, 36
B10.CAS3 c3 c3 c3 c3 c3 c3 c3 48, 53, 53
B10.CAS4(R28) c4(R28) c4 c4 c4 c4 c4 | b 53, 49, 58
B10.CAS3(R0) c3(R0) c3 c3 c3 ← b b b 46, 47, 50
F1:BALB/c.56-3 3
B10.CAS4(9887) c4(9887) c4 ← b b b b b 52, 56, 59, 51
F1 crosses were made between either the C3H.56-3 or BALB/c.56-3 lines carrying the recessive Cim2b alleles and the indicated inbred mouse
strains. ConA blast targets from the B27/hb2m transgenic F1 progeny mice were tested for lysis by Cim2a B27-restricted anti-HY CTL, as
described in the legend of Figure 1. In all cases where Cim2b CTL effectors were generated, reciprocal results were obtained (see Figure 2).
The mapping of the Cim2 locus between the A.TL and B10.CAS4(9887) crossover sites is indicated by horizontal arrows. Allele assignments
are taken from Klein (1986, 1989), Uematsu et al. (1988), Karlsson and Peterson (1992), K. F. L. (unpublished data), and T. Isobe and T. Shirioshi
(personal communication).
al., 1991), which was identified by transfection studies 21-4L (RT1 l) rats (Figures 1 and 2A, and Simmons et al.,
as the Tap2 locus (Powis et al., 1992). The dominant 1996). These results, indicating both gain and loss of
alleles of the RT1l, RT1lv1, and RT1av1 haplotypes in rats B27 HY epitopes, suggested that distinct but overlap-
and the H2b and H2s haplotypes in mice were designated ping sets of B27-bound HY peptides are generated
as Cim2a in both species, and the recessive alleles of within lymphoid cells in rats bearing these two MHC
haplotypes RT1c, RT1u, H2k, H2d, H2f, H2c3, and H2c4 were haplotypes. B27-restricted anti-HY CTL were also gen-
designated as Cim2b. It should be emphasized here that erated in B6.56-3 and BALB/c.56-3 mice by immuniza-
formal genetic mapping was only carried out in mice. tion with syngeneic male cells. As shown in Figures 2C
As noted above, we previously attributed the diallelic and 2D, these effectors showed the same reciprocal
effect of B27-restricted HY-specific lysis at the target patterns of lysis of B27 transgenic mouse and rat targets
cell level in rats to the functional dimorphism at the as were seen with the two classes of rateffectors. Similar
rat Tap2 locus (Simmons et al., 1996). However, the reciprocal patterns of lysis were seen when B27-
observation of a highly similar dimorphism in mice sug- restricted anti-HY CTL were generated in (C3H.56-3 3
gested that inboth species the effect was in fact attribut- B10.AKM)F1 and (C3H.56-3 3 B10.MBR)F1 mice (data
able to the new locus. As shown below, this suggestion not shown). Since these mice are genetically identical
was supported by the isolation of identical HY peptides except for the H2 region centromeric to H2-Ma (Table
from mice and rats and by the results of experiments 1 and Sachs et al., 1979), these results suggest that
with Tap2A transgenic rats. the same H2-linked dimorphic locus that controls the
generation of HY peptides bound to B27 also controls
the CTL response to these peptides.Reciprocal CTL Generation and Target Cell
We have previously determined that the HY antigenRecognition in Cim2a and Cim2b Rats
bound to B27 in 33-3 (RT1lv1, Cim2a) rats and recognizedand Mice, Based on Generation of
by CTL generated in RT1 l females is composed of twoOverlapping Sets of Peptides
peptides, KQYQKSTER and AVLNKSNREVR (SimmonsTo gain further insight into the nature of the polymor-
et al., 1997). To examine the HY peptides bound to B27phism at the Cim2 locus, we examined recognition of
in Cim2b PVG.33-3 rats (RT1c), peptides were isolatedrat and mouse targets by polyclonal B27-restricted, anti-
both from whole spleen cell extracts and from immuno-HY CTL generated in PVG.33-3 (RT1c) rats. As shown in
precipitated B27 molecules, and fractionated by HPLCFigure 2B, these CTL effectors showed a pattern of lysis
the reciprocal of that seen with effectors generated in by the same protocol previously used for the peptides
Immunity
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The same fractionation procedures were then carried
out on peptides isolated from B27 molecules immuno-
precipitated from detergent extracts of B6.56-3 and
BALB/c.56-3 mouse spleen cells (Figures 3C and 3D).
These yielded sensitizing fractions similar to those seen
in rats, i.e., one sensitizing peak (fraction 52 or 53) in
the Cim2a strains (F344 rat and B6 mouse) and three
sensitizing peaks (fraction 52 or 53, 71, and 74) in the
Cim2b strains (PVG rat and BALB/c mouse). As indicated
in Table 2, MS analysis showed concordance between
the masses of the peptide peaks in the corresponding
pairs of rat and mouse lines, based on functional Cim2
alleles, and the peptides in fractions 52±53 and 71 were
shown by tandem MS to share identical sequences in
rats and mice. These results strongly suggest identity
between the two species in the respective Cim2-linked
sets of HY peptides.
The peptide sensitization experiments shown in Fig-
ures 5A and 5B confirmed the overlapping but distinct
nature of the sets of HY peptides linked to Cim2a and
Cim2b. As previously described (Simmons et al., 1997),
the polyclonal CTL generated in Cim2a rats recognized
the synthetic peptides KQYQKSTER and AVLNKSN-
REVRadded to female B27/hb2m Cim2a targets, whereas
the corresponding CTL generated in Cim2b rats recog-
nized the synthetic peptides AVLNKSNREVR and AVLN
KSNREVY. These findings, as well as the authenticity of
the sequences determined by mass spectrometry, were
supported by the data from cold target inhibition assays.
As shown in Figure 5C and as previously described
(Simmons et al., 1997), the combination of KQYQKSTER
and AVLNKSNREVR accounted for all of the B27-pre-
Figure 2. Reciprocal Recognition of the Dimorphic B27-Presented sented HY antigenic activity in the Cim2a system,
HY Antigen on Rat and Mouse ConA Lymphoblasts by CTL from
whereas the combination of the two identified Cim2b HYCim2a and Cim2b Rats and Mice
peptides, AVLNKSNREVR and AVLNKSNREVY, showedPolyclonal B27-restricted, anti-HY CTL were generated in the re-
only partial inhibition of lysis of male B27/hb2m Cim2bspective rats or mice, as indicated, and tested for lysis of the indi-
targets by Cim2b CTL (Figure 5D), as would be expectedcated male (M) or female (F) targets. All targets shown were B27/
hb2m transgenic. Nontransgenic targets were not lysed (data not from the data identifying a third peak of HY peptide
shown). activity in this system (fraction 74, Figures 3B and 3D).
The Cim2a CTL showed some recognition of the AVLNK-
SNREVY peptide, suggesting that this peptide is not
isolated from 33-3 spleen. Analyses of whole cell ex- detected in Cim2a cells because it is not generated in
tracts and of immunoprecipiated B27 molecules both these cells.
identified three separate chromatographic peaks that
sensitized female PVG.33-3 and BALB/c.56-3 ConA A Rat Tap2A Transgene Does Not Affect
blast targets for lysis by anti-HY CTLeffectors generated Recognition of B27-Presented
in PVG.33-3 females (Figures 3A and 3B; data for whole HY Peptides
cell extracts not shown). Data from mass spectrometric Although the genetic mapping studies in the mouse
analysis of the sensitizing fractions is shown in Table 2 strongly suggested that the Cim2 locus is at least 60 kb
and Figure 4. In fraction 53, one peptide was detected centromeric to Tap, it was possible to test directly the
by matrix-assisted laser desorption ionization/time-of- effect of the rat Tap2A allele in Cim2b rats and mice by
flight (MALDI/TOF) mass spectrometry and its sequence expressing it as a transgene. Outbred Sprague Dawley
determined by quadrupole/orthogonal-acceleration rats (which bear RT1u and RT1b, both carrying Tap2B
time-of-flight (QTOF) mass spectrometry to be AV(I/ [Joly et al., 1994]), expressing a transgenic Tap2A con-
L)NKSNREVR, i.e., one of the two peptide sequences struct were produced,and progenyof this line (330-3) were
previously found eluting at the same position in the ex- crossed with PVG.33-3 rats to produce RT1u/c (Cim2b)
tracts from 33-3 rats (Simmons et al., 1997). Similarly, progeny transgenic either for both the B27/hb2m locus
in fraction 71, one peptide was identified with sequence and for Tap2A, or for B27/hb2m alone. Similarly, an in-
AV(I/L)NKSNREVY (Figure 4), which differs only at the bred B6 mouse line (150-1) transgenic for the Tap2A
C terminus and potentially at P3 from the peptide in construct was produced, which was then backcrossed
fraction 53. Fraction 74 contained several peptides, with twice to the BALB/c.56-3 line to produce progeny that
sequences obtained for three of them, but no sensitizing were either H2d/d or H2b/d, and transgenic either for both
B27/hb2m and Tap2A or for B27/hb2m alone.sequence has yet been identified.
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Figure 3. Sensitization Assays of Fractions
from RP-HPLC Separation of Peptide Popula-
tions from Immunoprecipitated B27 Mole-
cules Indicate Distinct Patterns for Cim2a and
Cim2b and Similar Patterns in Rats and Mice
(A) B27 peptide extract from 33-3 (F344) male
spleens, CTL from 21-4L rats, targets from
DA.33-3 females; (B) B27 extracts, CTL, and
targets from PVG.33-3 rats; (C) CTL from 21-
4L rats, extracts and targets from B6.56-3
mice; (D) CTL from PVG.33-3 rats, extracts
and targets from BALB/c.56-3 mice. Peptides
were isolated as described in Experimental
Procedures and separated in a 0%±70% ace-
tonitrile gradient in 0.1% TFA. The fractions
were lyophilized, and5% of each fraction was
tested for sensitization of the indicated fe-
male lymphoblast targets.
When male B27/hb2m/Tap2A/Cim2b targets from mice and mice. It was therefore of interest to investigate
whether the Cim2 alleles exert more general effects onand rats were compared with B27/hb2m/Cim2b targets
for lysis by either Cim2a or Cim2b CTL effectors, there the spectrum of peptides presented by B27. Spleen cells
from Cim2a and Cim2b mice were therefore metabolicallywas no effect of the Tap2A transgene on the reciprocal
patterns of lysis characteristic of Cim2a and Cim2b ef- labeled with 3H-Arg, and the peptides extracted from
immunoprecipitated B27 molecules were analyzed byfector CTL (data not shown). This provides further evi-
dence that in both rats and mice, the effect attributed RP-HPLC under identical conditions. As shown in Fig-
ure 6A, the population of B27-bound peptides in Cim2bto theCim2 locus functions independently of the allelism
at the Tap2 locus. mice (BALB/c.56-3) eluted from the column significantly
This result could only be considered valid if the Tap2A later than the corresponding peptides in Cim2a mice
transgene expresses a functional protein product. To (BALB.B.56-3), indicating that a polymorphic H2-linked
confirm that this was the case, peptide transport was locus exerts a broad effect on the peptides bound by
examined in hepaticmicrosomes from Tap2A transgenic B27, similar to that previously described in rats (Simmons
and nontransgenic mice and rats. The peptides TYQR et al., 1996). To relate this result to the data mapping
TRALH, TYQRTRALR, and TYQRTRALK were tested for the Cim2 locus, the experiment was repeated using 3H-
theirability to inhibit ATP-dependent microsomal uptake Arg-labeled spleen cells from (C3H.56-3 3 B10.AKM)F1
of a library of 125I-labeled indicator peptides. In micro- and (C3H.56-3 3 B10.MBR)F1 mice. The results, shown
somal preps from Tap2A transgenic mice and rats, these in Figure 6B, formally map the broad effect on B27 pep-
three peptides with basic C termini competed with the tide binding to the same region of H2 to which the Cim2
indicator peptides more successfully than in micro- effect on the B27 HY antigen was mapped, i.e., centro-
somes from nontransgenic B6 mice and nontransgenic meric to the Ma±Tap±Lmp complex.
Tap2B rats, respectively (data not shown). This is the To test whether this influence extends to the peptides
result that would be predicted, based on previous func- binding to endogenous mouse MHC class I, the Lq/Dq
tional data for TAP transporters (Heemels and Ploegh, molecules were immunoprecipitated with the mono-
1994; Momburg et al., 1994). The competition in Tap2A clonal antibody 28-14-8S from the labeled spleen cell
transgenic rat microsomes was intermediate between extracts of (C3H.56-3 3 B10.AKM)F1 and (C3H.56-3 3
that from nontransgenic Tap2B and nontransgenic B10.MBR)F1 mice used to obtain B27 molecules, and
Tap2A rats, but the vector used is only weakly expressed the bound peptides were analyzed in the same manner
in liver in transgenic animals and much more strongly as described for the B27 peptides. As shown in Figure
expressed in spleen. Therefore, given the detection of 6C, a marked dimorphic effect of the Cim2 region on
measurable Tap2A transgene function even in liver, it is these peptides was also observed. The positions of the
reasonable to assume that there is effective expression respective peptide elutions were consistent with the
of the transgene in lymphoblasts. observation that mouse class I molecules show a strong
preference for hydrophic peptides, particularly in con-
trast to HLA-B27 (Rammensee et al., 1995). Nonethe-Cim2 Affects a Broad Spectrum of Peptides
Bound to B27 and to Mouse MHC less, the data suggest that even in the case of a mouse
class I molecule, the Cim2b allele is associated withClass I Molecules
The foregoing results identifying the Cim2 locus only display of a more hydrophobic peptide population than
Cim2a.relate it to the set of HY peptides bound to B27 in rats
Immunity
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Figure 4. Mass Spectrometric Sequence Determination of the Major Component of HPLC Fraction 71 B27 Molecules Isolated from Male
PVG.33-3 Rats (Shown in Figure 3B)
Collisional activation of the [M12H]21 ion generated by electrospray yielded partial sequence information. An equivalent analysis after
N-acetylation yielded the product ion spectrum shown. The major fragment ions may be attributed to b- and y-series ions, with charge
retention on the N and C termini, respectively. Comparison of the spectra obtained before and after N-acetylation enabled differentiation
between isobaric (129 Da) K and Q residues, as previously described (Simmons et al., 1997).
This result might have been influenced by the pres- et al., 1989, 1991). Although a modest degree of se-
quence polymorphism has recently been described inence of hb2m, which is known to affect the expression
the Tap1 and Tap2 genes of laboratory mouse strainsof mouse MHC class I molecules (Martien van Santen
that might produce subtle, as yet unidentified, functionalet al., 1995). To exclude this possibility, to test the influ-
polymorphism (Marusina et al., 1997), the genetic map-ence of the Cim2 region on another mouse allele, and to
ping unequivocally separates the Cim2 locus from thefurther genetically map this phenotypic effect on peptide
Tap±Lmp region.profiles and assess dominance and recessivity with re-
Our data do not formally exclude the possibility thatspect to it, we compared the peptides bound to H2-Db
the principal role of the Cim2 locus in the production ofmolecules in the context of the H2b (Cim2a) and the
the different sets of HY peptides is an interaction, eitherrecombinant CAS4(9887) (Cim2b) haplotypes from non-
direct or indirect, with a product of the Y chromosome,transgenic mice. As shown in Figures 6D and 6E, the
rather than as a factor more generally influencing classdimorphic effect of the Cim2 region on these peptides
I peptide display. In this case, the Cim2 locus couldwas even more dramatic than on Lq/Dq peptides. More-
either encode the polymorphic protein from which oneover, the genetic mapping and pattern of dominance
or more of the B27-presented HY antigenic peptideswere identical to those established for the effect on B27-
arises, or its product could participate indirectly, butpresented HY peptides, supporting the concept that
polymorphically, in the generation of one or more ofthese traits are both controlled by the same locus.
these peptides, but through a specific interaction with
a Y-chromosome-encoded factor. However, we also
Discussion found that Cim2a and Cim2b mice show spectra of bound
peptides that are quite distinct from each other, both in
We have presented immunogenetic and biochemical ev- the case of B27 and in the case of the endogenous Dq,
idence for the existence of a gene (or possibly genes) in Lq, and Db class I molecules, and thus it seems far more
mice and rats, the product of which significantly affects likely that the product of the Cim2 locus has a more
peptide presentation by HLA-B27. In mice, the locus general role inpeptide displayby MHC class Imolecules.
maps within the MHC to the region between the K and Until the gene responsible for the Cim2 effect is cloned,
Pb loci, and, as noted above, it is therefore distinct from it will not be possible to determine formally whether it
Tap, Lmp, and the locus encoding tapasin. We have is the same locus that accounts for the differing sets of
named this locus Cim2, based on the similarity of its B27-presented HY peptides on the one hand, and the
differing spectra of MHC-bound peptides on the other,action to the cim gene described in the rat (Livingstone
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Table 2. Sequence Analysis of HY Antigenic Peptides Eluted from Purified B27 Molecules from Mice and Rats: Effect of Cim2 Alleles
Mass Spectrometric Analyses
Sensitizing Molecular
CTL Effectors Spleen Source HPLC Fraction Mass (Da) Sequence
21-4L (Cim2a) 33-3 (Cim2a) 53 1166.4 KQYQKSTERa
1284.6 AVLNKSNREVRa
B6.56-3 (Cim2a) 52 1166.6 KQYQKSTER
1284.7 AV(L/I/NKSNREVR
PVG.33-3 (Cim2b) PVG.33-3(Cim2b) 53 1284.7 AV(L/I)NKSNREVR
71 1291.7 AV(L/I)NKSNREVY
BALB/c.56-3 (Cim2b) 52 1284.7 AV(L/I)NKSNREVR
71 1291.7 AV(L/I)NKSNREVY
Mass spectrometric analysis by QTOF was carried out on the sensitizing peptide fractions identified in Figure 3, as described in Figure 4 and
Experimental Procedures. Data for the peptides from fraction 74 is not shown, since characterization of biological activity of the peptides
from this fraction is in progress. None of the B27-presented HY peptide sequences completely match known protein sequences. The homologies
of the KQYQKSTER and AVLNKSNREVR peptides have been discussed elsewhere (Simmons et al., 1997). Presumably AVLNKSNREVR and
AV(L/I)NKSNREVY are related to each other as either (i) imperfect repeats within the same protein, (ii) alternatively spliced forms of the same
protein, or (iii) derivatives of isotypic proteins.
a Sequence previously determined and reported (Simmons et al., 1997). In that study, the L/I ambiguity of the peptide AVLNKSNREVR was
resolved by Edman sequencing.
but this seems likely, based on the identical patterns of either in the cytosol or in the ER, as a part of the TAP
complex, as a transcription factor, as an alternative pep-dominance and recessivity.
There are many potential sites of action for the protein tide transporter, or as a regulator of tapasin or TAP. The
most direct resolution of this question will presumablyproduct(s) of the Cim2 locus, and at this point we can
only speculate regarding function. Any of the known come with cloning the Cim2 gene(s) and characterizing
the product(s).steps in the pathway of class I peptide presentation
could be affected: generation of peptide within the cyto- As noted above, although the Cim2 locus was not
genetically mapped in the rat, its behavior in rats issol, binding of peptide to TAP, transport of peptide by
TAP into the ER, processing of peptide within the ER, virtually identical to the locus that was mapped within
the K-Pb interval in the mouse, and its function couldegress of peptide from the ER, progression of class I
assembly in the ER, binding of class I to TAP or to not be replicated by introduction of a rat Tap2A transgene
into Cim2b, Tap2B rats. On these grounds, we concludetapasin, binding of class I to peptide, or intracellular
transport of assembled heavy chain/b2m/peptide com- that the Cim2 locus in the rat is distinct from Tap and
predict that it will prove homologous to the locusplexes (Heemels and Ploegh, 1995; Lehner and Cress-
well, 1996; York and Rock, 1996; Koopmann et al., 1997; mapped in the mouse. This is supported by the observa-
tion that known genes within the K-Pb interval in theOrtmann et al. 1997). The product of Cim2 might thus
function, for example, as a component of the ubiquitina- mouse show a high degree of synteny conservation
among mice, rats, and humans (Nagata et al., 1995;tion apparatus or of the proteasome, as a chaperone
Figure 5. Presentation of Synthetic Peptides
in Direct and Cold-Target Inhibition CTL
Assays
Rat Cim2a and Cim2b CTL were produced in,
respectively, 21-4L and PVG.33-3 rats, and
the Cim2a and Cim2b lymphoblast targets
used (male and female) were from DA.33-3
and PVG.33-3 rats, respectively. All assays
were carried out at an E:T (labeled target) of
75:1.
(A and B) Female target cells were sensitized
with 10 nM of the indicated peptides and
tested for lysis by the polyclonal CTL popula-
tions, as indicated.
(C and D) 51Cr-labeled male target cells were
assayedin the presence of the indicated unla-
beled targets. Sensitized cold targets were
incubated with 10 nM peptide and washed
before addition to the CTL assay.
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Walter et al., 1996). It would have been quite difficult to
identify the Cim2 locus in rats if the only data available
were functional characterization of the five RT1 haplo-
types studied, since in each one, the effect of the Cim2
allele on the B27 HY antigen showed concordance with
the known Tap2 allele on the same haplotype. This con-
cordance is manifest on two levels. In the simple sense,
it may represent linkage disequilibrium, since only two
combinations of alleles were identified out of the four
that are theoretically possible. However, at a functional
level also, the linked alleles share dominance (Cim2a
and Tap2A) or recessivity (Cim2b and Tap2B). Moreover,
the alternative HPLC peptide profiles linked to the Cim2
alleles are similar to those seen with RT1.Aa, attributed
to the cim/Tap2 alleles (Powis et al., 1992). It was these
observations that led to the initial, now apparently inac-
curate, conclusion that the RT1-linked effect upon B27
CTL recognition could be attributed to the Tap2 locus
(Simmons et al., 1996). However, it should be noted that
the previously described effects of the rat Tap2 alleles
on RT1.Aa (Livingstone et al. 1989, 1991; Powis et al.,
1992) were observed in the context of both putative rat
Cim2b (through transfections of a cell line carrying the
RT1u haplotype) and putative Cim2a (in the congenic
PVG.R1 strain, the recombination site for which has
been mapped telomeric to the interval homologous to
H2-K-Pb [Carter and Fabre, 1991]). The Cim2 phenom-
ena described here are thus distinct from the estab-
lished Tap2/cim effect on RT1.Aa.
Nonetheless, if the product of the Cim2 locus some-
how affects peptide transport, either in cooperation with
the TAP transporter or independently, it may be neces-
sary to reinterpret someof thedata from studies examin-
ing RT1-linked peptide transport, in which it was as-
sumed that all of the observed affects were attributable
to the Tap2 alleles. Some of these studies have used
cell lines transfected with the Tap2 alleles, whereas oth-
ers have used tissues from rats bearing different RT1
haplotypes. In studies of the first type, the Cim2 alleles
would remain fixed, whereas in the second type, theyFigure 6. Mouse Cim2a and Cim2b Haplotypes Are Associated with
would vary along with the Tap2 alleles. In this regard,Markedly Different Peptide Display by Both B27 and Endogenous
it is of interest that Heemels and Ploegh (1994) examinedMouse Class I Alleles
peptide transport into rat hepaticmicrosomes and foundB27 molecules (A and B) Lq and Dq molecules (C), and Db molecules
(D and E) were immunoprecipitated from detergent lysates of spleen that the transporter function in rats carrying Tap2B was
cells pooled from two of each of the indicated mice, metabolically more relaxed in its peptide length preference, whereas
labeled with 3H-Arg. The bound peptides were eluted and separated Momburg et al. (1994), using permeabilized human T2
by RP-HLPC, as in Figure 3, and the resulting fractions counted for cells expressing transfected rat Tap genes, found the3H. For both the B27 transgene product and the endogenous alleles,
opposite. Although these two assay systems are differ-Cim2b is recessively associated with loading of a significantly later
ent, they have tendedto yieldconcordant results regard-eluting, presumably more hydrophobic, population of peptides than
ing transport of peptides with varying C-terminal resi-Cim2a. The H2m haplotype of B10.AKM and the H2bq1 haplotype of
B10.MBR are related by a single crossover event (Sachs et al., 1979), dues. This raises the possibility that one or more
and are identical telomeric to Pb (Table 1) and hence share identical additional genes that differ between human and rat,
alleles in the D region. The Dq region of both haplotypes encodes or that are deleted in T2 cells, may also contribute to
both Lq and Dq molecules that share 97% protein sequence homol- antigenic peptide transport. The Cim2 locus would be
ogy and strong immunologic crossreactivity, and both are reactive
a candidate for this inferred effect.with the MAb 28-14-8S (Ozato et al., 1980; Lee et al., 1988). For
Other results are also consistent with that suggestionthe results shown in (D) and (E), the mice were F2 progeny of a
that not all of the factors that participate in peptideB10.CAS4(9887) 3 B6 cross, and were typed for H2-Kb and for H2-
Kc4 with the MAb B8-24-3 and H100-5/28, respectively (Uematsu et loading of class I molecules have been identified. For
al., 1988). Db molecules were immunoprecipitated with the MAb 28- example, (1) the EBV-transformed human MHC deletion
14-8S. The results shown in (D) are for mice that were homozgous, mutant cell line 721.174 lacks both TAP and LMP genes.
respectively, for H2b and for the H2c4(R9887) recombinant haplotype, Transfection with TAP1 and TAP2 restored class I ex-
and in (E) for mice that were heterozgous for these two haplotypes.
pression and viral peptide presentation. However, de-
fective presentation of certain influenza epitopes per-
sisted in TAP-transfected 721.174 cells (Cerundolo et
New MHC Locus Influencing Class I Peptides
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Mice and rats transgenic for the rat Tap2A allele were producedal., 1995). These authors found that expression of LMP2
by pronuclear microinjection, as previously described (Taurog et al.,and LMP7 as well as the TAP genes in these cells failed
1988; Hammer et al., 1990), using a construct in which a Tap2a cDNAto restore the influenza NP peptide presented by H2-
(Powis et al., 1991b, the gift of Dr. Geoffrey Butcher, Babraham, UK)
Db, and they raised the possibility of an additional defect was subcloned into the pHSE39 expression vector, under direction of
within this cell line. (2) A kindred was described carrying the H2-Kb promoter (Pircher et al., 1989). In preliminary experiments,
stable transfection of this construct increased surface expressionan HLA haplotype that conferred a defect in the presen-
of H2 class I in RMA-S cells, which have a defective Tap2 genetation of some viral peptides by HLA-B*2702 contained
(Powis et al., 1991b). The transgene was detected in tail biopsywithin this haplotype and also by HLA-B8, not attribut-
genomic DNA by dot blot hybridization with a probe derived from theable to any defects in the HLA-B*2702, TAP1, or TAP2
fragment of the human b-globin gene contained within the vector.
genes (Pazmany et al., 1992; Rowland-Jones et al., Typing for the HLA-B27 transgene was by dot blot hybridization,
1993). The peptides bound to the B*2702 molecules as previously described (Hammer et al., 1990), or by ELISA detection
of soluble B27/hb2m complexes in serum (Pouletty et al., 1994).from an EBV-transformed B cell line from the index case
Typing for RT1 and H2 alleles was by flow cytometry on peripheralshowed a slightly altered HPLC elution profile, com-
blood leukocytes, as previously described (Taurog et al., 1988; Sim-pared with peptides carried on control B*2702 cell lines,
mons et al., 1993, 1996, 1997), or with 3H-labeled MAb, as previouslyand the affected cell line was lysed by most but not all
described (Uematsu et al. 1988).
of a panel of alloreactive anti-B27 CTL (LoÂ pez et al.,
1994). (3) In a study of peptide binding and transport CTL Effectors and Assay
in insect cells carrying overexpressed TAP1 and TAP2 Polyclonal B27-restricted, anti-HY rat CTL effectors were generated
as previously described (Simmons et al., 1993, 1996, 1997). Briefly,genes (van Endert et al., 1994), it was observed that the
female 21-4L or PVG.33-3 rats were primed in vivo against rat malespecific activity of human TAP in insect cells was only
HY antigen by subcutaneous and intraperitoneal injection of 2 3z10% of that in human cells, and the authors speculated
108 pooled lymph node cells (LNC) and spleen cells from male 21-4L
that additional factors absent in insect cells may be or PVG.33-3 rats, respectively. LNC harvested from primed females
required for optimal TAP activity. (4) In a study of immune were cultured with fresh, irradiated (3000R) syngeneic transgenic
function in two siblings with an autosomal recessive male LNC stimulator cells in complete RPMI 1640 for 4±5 days in
96-well U-bottom plates at 1 3 105 responder and 3 3 105 stimulatornonsense mutation disrupting the TAP2 gene (de la Salle
cells/well. 51Cr release assays of 4 hr each were carried out in tripli-et al., 1997), the anomaly was observed that the subjects
cate, as described (Simmons et al., 1993), with ConA blast LN (rat)showed very low surface class I expression and abnor-
or spleen (mouse) lymphoblasts as targets. B27-restricted anti-HY
mal instability of the class I molecules, but they nonethe- CTL were similarly produced from spleen cells of B27/hb2m
less showed apparently normal resistance and humoral transgenic female mice primed in vivo with syngeneic male cells,
immunity to viral infections, an ability to express viral as described for rats. Sensitization assays, cold target inhibition,
and peptide synthesis were all as previously described (Simmonspeptides in surface-expressed HLA-B molecules, and
et al., 1997).at least some ability to generate CD81, HLA-restricted
CTL. The authors emphasized the implications for TAP-
Purification and Sequencing of HY Peptides Boundindependent antigen processing from these results.
to HLA-B27
Taken together, these findings suggest that one or more These procedures were carried out as previously described in detail
as-yet-unidentified proteins plays a role in the complex (Simmons et al., 1997). Briefly, spleen-cell suspensions from B27
process of class I peptide acquisition and display. It will transgenic rats and mice were lysed in buffer containing 1% hydro-
genated Triton X-100 (Calbiochem), the B27 molecules were immu-be of interest to see if any of the phenomena can be
noprecipitated with the MAb B1.23.2 and protein A±agarose beadsexplained by the product(s) of the Cim2 locus.
(Boehringer-Mannheim), and the bound peptides were dissociated
by treatment with 0.1% TFA. Alternatively, the spleen cells were
lysed and extracted with 0.1% TFA. In either case, the peptideExperimental Methods
fraction was purified by elution from a Sep-Pak column, and the
peptide population was fractionated by reverse-phase HPLC withAnimals
a 4.6 3 200 mm Aquapore RP300 column (Applied Biosystems Divi-The 56-3 transgenic mouse line expressing HLA-B*2705 and hb2m
sion of Perkin-Elmer, Foster City, CA) in a linear gradient of 0%±70%has been previously described (Taurog et al., 1990; Hammer et
acetonitrile in 0.1% TFA. The resulting 0.5 ml fractions were lyophi-al., 1990; Simmons et al., 1993). The 56-3 transgene locus was
lized and resuspended in 100 ml of water, and 5 ml of each fractionbackcrossed >10 generations onto the following backgrounds:
was tested for sensitization of B27 female ConA blast targets to lysisC57BL/6J, BALB/cJ/By, C3H/HeJ, SJL/J, and MRL/MpJ. These
by anti-HY, B27-restricted CTL. Initial screening of the sensitizingtransgenic lines are maintained by typing for the hemizygous
fractions for peptide masses and sample heterogeneity was per-transgene locus in each backcross generation, as previously de-
formed by matrix-assisted laser desorption ionization (MALDI), usingscribed (Simmons et al., 1993, 1997). The lines are referred to as
a Voyager DE MALDI-TOF mass spectrometer (PerSeptive Biosys-B6.56-3, BALB/c.56-3, etc. For some experiments, F1 crosses were
tems, Inc., Framingham,MA). The primary sequences of the targetedproduced between either the C3H.56-3 or BALB/c.56-3 mice and
peptides were determined by tandem mass spectrometry. High sen-mice carrying particular H2 haplotypes and/or backgrounds of
sitivity for these analyses was accomplished by the combination ofinterest. The following lines from Dr. Fischer Lindahl's colony at
low flow-rate electrospray together with a quadrupole/orthogonal-UT Southwestern were crossed with C3H.56-3 or BALB/c.56-3:
acceleration time-of-flight instrument (QTOF) (Micromass).B10.CAS3, B10.CAS4(R28), B10.CAS3(R0), and B10.CAS4(9887) (all
4 designated /Kfl). The other inbred mouse stocks shown in Table
1 were from The Jackson Laboratory, where most of the rest of the Elution of 3H-Labeled Peptides from HLA-B27
and Mouse Class I Moleculesbreeding was carried out.
The B*2705/hb2m transgenic rat lines 21-4L, DA.33-3, and This was carried out as previously described (Simmons et al., 1996),
with some modifications. Mouse spleen cells (5 3 107, pooled fromPVG.33-3 (LEW, DA, and PVG backgrounds, respectively), were pro-
duced and housed as described (Hammer et al., 1990; Simmons et two mice) were metabolically labeled for 5 hr with 250±500 mCi
of 3H-arginine (Amersham). Immunoprecipitations from cell lysatesal., 1993, 1996). The cim and Tap2 alleles for the rat strains are:
LEW, F344, DA (cima, Tap2A), and PVG (cimb, Tap2B) (Livingstone were carried out with the MAb B1.23.2 (Taurog et al., 1993) for HLA-
B27 molecules and 28-14-8S (Ozato et al., 1980) for H2-Lq/Dq oret al., 1991; Joly et al., 1994).
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H2-Db molecules, followed by protein A±agarose, with subsequent (1993). Peptide translocation by variants of the transporter associ-
ated with antigen processing. Science 262, 2059±2063.steps for HPLC separation as described in the preceding paragraph.
b emissionof each 0.5 ml fraction was counted by liquid scintillation. Heemels, M.-T., and Ploegh, H.L. (1994). Substrate specificity of
allelic variants of the TAP peptide transporter. Immunity 1, 775±784.
Peptide Transport Assay Heemels, M.-T., and Ploegh, H. (1995). Generation, translocation,
Translocation of peptide into rat and mouse hepatic microsomes and presentation of MHC class I±restricted peptides. Annu. Rev.
Biochem. 64, 463±491.was carried out as previously described (Heemels et al., 1993;
Heemels and Ploegh, 1994), with minor modifications. ATP-depen- Joly, E., Deverson, E.V., Coadwell, J.W., Gunther, E., Howard, J.C.,
dent microsomal uptake of a library of 125I-labeled nonamer peptides and Butcher, G.W. (1994). The distribution of Tap2 alleles among
was measured in the presence of varying concentrations of competi- laboratory rat RT1 haplotypes. Immunogenetics 40, 45±53.
tor peptides TYQRTRALR, TYQRTRALK, or TYQRTRALH. The syn- Karlsson, L., and Peterson, P.A. (1992). The a chain gene of H-2O
thetic peptide library used as a reporter substrate has a variable has an unexpected location in the major histocompatibility complex.
COOH terminus and is based on the sequence of the peptide TYNR- J. Exp. Med. 176, 477±483.
TRALI, containing a tyrosine residue for labeling and the N-glycosyl-
Klein, J. (1986). Natural History of the Major Histocompatibility Com-ation consensus sequence NXT (Heemels et al., 1993). Peptide bind-
plex. (New York: John Wiley and Sons).ing to ConA Sepharose beads (Pharmacia, Uppsala, Sweden) was
Klein, J. (1989). Congenic and segregating inbred strains. In Geneticassessed by g counting. Percentage of peptide uptake was deter-
Variants and Strains of the Laboratory Mouse, M.F. Lyon and A.G.mined by the formula:
Searle, eds. (Oxford, UK: Oxford University Press), pp. 747±797.
Koopmann,J.-O., HaÈ mmerling, G.J., and Momburg, F. (1997). Gener-(CPM1ATP1competitor 2 CPM2ATP) 3 100
CPM1ATP 2 CPM2ATP ation, intracellular transport and loading of peptides associated with
MHC class I molecules. Curr. Opin. Immunol. 9, 80±88.
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